These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 826167

  • 21. Effect of phorbol esters on alloimmune cytolysis.
    Munger WE, Lindquist RR.
    Cancer Res; 1982 Dec; 42(12):5023-9. PubMed ID: 6814749
    [Abstract] [Full Text] [Related]

  • 22. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.
    Sakai K, Chang AE, Shu SY.
    Cancer Res; 1990 Jul 15; 50(14):4371-6. PubMed ID: 2114215
    [Abstract] [Full Text] [Related]

  • 23. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE, Cerottini JC, Brunner KT.
    Eur J Immunol; 1979 Mar 15; 9(3):179-84. PubMed ID: 221224
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.
    Maas RA, Roest PA, Becker MJ, Weimar IS, Dullens HF, Den Otter W.
    Immunobiology; 1992 Nov 15; 186(3-4):214-29. PubMed ID: 1490728
    [Abstract] [Full Text] [Related]

  • 28. Anti-estrogens potentiate the immunotherapy of the P815 murine mastocytoma by cytotoxic T lymphocytes.
    Nagy E, Baral E, Kangas L, Berczi I.
    Anticancer Res; 1997 Nov 15; 17(2A):1083-8. PubMed ID: 9137453
    [Abstract] [Full Text] [Related]

  • 29. Effects of Tumor-like assay conditions, lonizing radiation, and hyperthermia on immune lysis of tumor cells by cytotoxic T-lymphocytes.
    Harris JW.
    Cancer Res; 1976 Aug 15; 36(8):2733-9. PubMed ID: 6145
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
    Knisely TL, Luckenbach MW, Fischer BJ, Niederkorn JY.
    J Immunol; 1987 Jun 15; 138(12):4515-23. PubMed ID: 3108394
    [Abstract] [Full Text] [Related]

  • 32. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W, Lundeen KA, Kohrumel JR, Pham NL, Brostoff SW, Bartholomew RM, Carlo DJ.
    J Immunol; 1999 Jun 15; 162(12):7343-9. PubMed ID: 10358185
    [Abstract] [Full Text] [Related]

  • 33. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
    Laatikainen A, Syrjänen K, Mäntyjärvi R, Tosi P.
    Arch Geschwulstforsch; 1987 Jun 15; 57(4):265-74. PubMed ID: 3118852
    [Abstract] [Full Text] [Related]

  • 34. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes.
    Matsumura T, Sussman JJ, Krinock RA, Chang AE, Shu S.
    Cancer Res; 1994 May 15; 54(10):2744-50. PubMed ID: 8168105
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. "Nonspecific" immunoenhancing T cells in tumor-bearing mice include anti-idiotypic subsets.
    Behforouz N, Eardley DD, Cerny J.
    J Immunol; 1983 Nov 15; 131(5):2576-9. PubMed ID: 6226744
    [Abstract] [Full Text] [Related]

  • 37. Analysis of cytotoxic T cell responses to intracameral allogeneic tumors.
    Ksander BR, Streilein JW.
    Invest Ophthalmol Vis Sci; 1989 Feb 15; 30(2):323-9. PubMed ID: 2492486
    [Abstract] [Full Text] [Related]

  • 38. The antimetastatic function of concomitant antitumor immunity. I. Host Ly-1+2+ effector T cells prevent the enumeration of metastatic tumor cells in a biological assay.
    Dye SE.
    J Immunol; 1986 Feb 15; 136(4):1504-9. PubMed ID: 3080525
    [Abstract] [Full Text] [Related]

  • 39. Stimulator T cells: involvement in the induction of cell-mediated cytotoxicity.
    Dennert G.
    J Immunol; 1975 May 15; 114(5):1570-3. PubMed ID: 804519
    [Abstract] [Full Text] [Related]

  • 40. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC, Prager MD.
    Cancer Res; 1977 Feb 15; 37(2):507-13. PubMed ID: 832275
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.